The first ever treatment for Australians with a rare neurodegenerative disease could help slow the progression of its damage ...

The funds will be used to increase the development of GAIA-based Alzheimer's disease drugs and widen the pipeline of blockbuster drug candidates.

Biohaven Ltd. (NYSE:BHVN) is one of the Best 52-Week Low Stocks to Buy According to Analysts.. On June 10, Biohaven Ltd.

For chronic pain patients, though, the brain interprets even neutral sensations as pain and suffering. In effect, pain ...

Dublin, June 16, 2025 (GLOBE NEWSWIRE) -- The "Central Nervous System Therapeutics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for ...

Big Biotech Biogen is venturing into the city, paying $16 million in cash to partner up with an RNAi company to build next-gen central nervous system drugs. The research pact—inked with recently ...

The chemotherapy drug class ranked 4th in total shortages in the ASHP analysis, behind central nervous system drugs, antimicrobials, and hormone agents, respectively.

Lilly told the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee that its data from late-stage clinical research showed “highly meaningful results” for patients who took ...

In an 11-0 vote, the Peripheral and Central Nervous System Drugs Advisory Committee said the benefits of donanemab outweighed its risks for the population of Alzheimer's disease patients with mild ...

Did you know that certain medications can cause symptom of 'Central nervous system stimulation'. Find these drugs listed on the page and be warned of similar symptoms as possible side-effects.